Allison Atlas
Women's Health · McKinney, TXNPI 1508182627
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.3% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 28.1% of the total. Among women's health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$690
- Astellas Pharma US Inc$597
- Biohaven Pharmaceutical Holding Company Ltd.$147
- Mayne Pharma Commercial LLC$103
- Exeltis, USA Inc.$100
- Aspira Women's Health Inc$94
- plus $727 from 18 others
What the payments were for
- Food & beverage$2,29593%
- Education$1657%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $690 |
| Astellas Pharma US Inc | 15 | $597 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $147 |
| Mayne Pharma Commercial LLC | 7 | $103 |
| Exeltis, USA Inc. | 6 | $100 |
| Aspira Women's Health Inc | 2 | $94 |
| Novo Nordisk | 5 | $94 |
| Lilly USA, LLC | 5 | $78 |
| Pfizer | 3 | $65 |
| Corcept Therapeutics | 2 | $62 |
| Organon | 3 | $58 |
| Dexcom, Inc. | 3 | $55 |
| Currax Pharmaceuticals LLC | 3 | $44 |
| Amgen | 3 | $42 |
| Alfasigma USA, Inc. | 2 | $31 |
| Therapeuticsmd, Inc. | 2 | $29 |
| Ascensia Diabetes Care US Inc. | 1 | $28 |
| Avion Pharmaceuticals | 2 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| Minerva Surgical, Inc | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Vivus LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$239
- NURTEC ODT$125
- QULIPTA$125
- UBRELVY$125
How this compares
$2,460 in reported general payments places this provider in the 90th percentile of 609 women's health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 31 | $1,650 |
| Estradiol | 17 | $722 |
Paid to pharmacies, not to this prescriber.
Other women's health in McKinney
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Shelagh LarsonFort Worth$43K
- Amanda ArmondAustin$17K
- Joann St PierreHouston$15K
- Christina BlancoEl Paso$14K
- Ricshonda MilburnGalveston$13K
- Sandra EastlingLubbock$12K
- Lori WinkHouston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.